Stifel Financial
VRCA icon

Stifel Financial’s Verrica Pharmaceuticals VRCA Stock Holding History

Stifel Financial’s Portfolio VRCA Stock Details VRCA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-1,391
Closed -$20.2K – 3490
2024
Q3 		$20.2K Sell
1,391
-344
-20% -$15.5K ﹤0.01% 3341
2024
Q2 		$126K Sell
1,735
-315
-15% -$24.2K ﹤0.01% 3180
2024
Q1 		$121K Hold
2,050
– – ﹤0.01% 3173
2023
Q4 		$150K Hold
2,050
– – ﹤0.01% 3107
2023
Q3 		$79.6K Buy
+2,050
New +$104K ﹤0.01% 3141
2023
Q1 		– Sell
-1,613
Closed -$44.3K – 3432
2022
Q4 		$44.3K Buy
+1,613
New +$43K ﹤0.01% 3198

Other funds holding VRCA

AC
Armistice Capital New York $3.03B AUM 36.06% 1-Year Est. Return
CP
Caligan Partners New York $1.41B AUM 518.95% 1-Year Est. Return
PA
Perceptive Advisors New York $5.06B AUM 314.02% 1-Year Est. Return
BFM
Boothbay Fund Management New York $4.34B AUM 106.31% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
SA
Sovran Advisors San Diego, California $1.27B AUM 18.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return